AI could help spot baby hip issues earlier
NCT ID NCT07488260
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether an artificial intelligence (AI) software can accurately analyze hip ultrasound images from infants screened for developmental dysplasia of the hip (DDH). About 150 babies will have their routine hip ultrasound read by both a doctor and the AI, and researchers will compare the results. If the AI matches the doctor's diagnosis often enough, it could become a helpful tool for faster or more consistent screening.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- AI-supported hip ultrasound analysis software (Prelux)
- What this could lead to
- If successful, this AI tool could help doctors more quickly and consistently diagnose hip dysplasia in infants, potentially catching cases earlier.
- What could go wrong
- This is an early-stage study with only 150 infants, and the AI may not match the accuracy of trained physicians. It is designed to assist, not replace, doctors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 150 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2026
An estimate. Start dates often move.
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
4 weeks to 6 months
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Participants whose Parent(s) or Legally Authorized Representative(s) have provided written informed consent; 2. Participants who need to undergo routine DDH screening and receive an ultrasound as part of the clinical investigation; 3. Participants of either sex aged between 4 weeks and 6 months weeks. Exclusion Criteria: 1. Participants with open wounds, ulcers, burns, viral or bacterial infections at the site intended for examination; 2. Participants with significant anatomical abnormalities (e.g. cerebral palsy, joint contracture, suppurative coxitis, other hip or limb deformities, or teratological hip dysplasia) that may affect the feasibility or accuracy of the examination; 3. Participants with history of trauma, surgical intervention, or post-traumatic/post-surgical condition in the area to be examined.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Developmental dysplasia of the hip (DDH) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.